Here are key updates of India's COVID-19 vaccine journeyCovaxin, India's first coronavirus vaccine has been developed by Bharat Biotech developed by Bharat BioTech, Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
The clinical trial to verify the safety of potential COVID-19 vaccine has started in August. "There had been 'no side effects' in the phase I trial of Covaxin," Dr E Venkata Rao, principal investigator of the trial at Institute of Medical Sciences and SUM Hospital, faculty of medical sciences, said.ZyCoV-D, developed by Zydus Cadila began its phase II clinical trials from August 6. "The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial,.